NDC codes

364943 NDC codes with hospital pricing data in the network.

• NDC 44567-0845-25 — ceFAZolin 3 gram intravenous solution (164 hospitals, 143–701 samples)
• NDC 904530661 — Diphenhydramine HCl Cap 25 MG (92 hospitals, 494–701 samples)
• NDC 63459-0910-11 — GRANIX 300 MCG/0.5ML SC SOSY (649 hospitals, 467–701 samples)
• NDC 73177-0149-43 — METHADONE 1 MG/ML (1 ML) IN 0.9 % SODIUM CHLORIDE INTRAVENOUS SYRINGE (40 hospitals, 503–701 samples)
• NDC 00143-9383-01 — CEFEPIME HCL FOR IV SOLN 2 GM (108 hospitals, 170–701 samples)
• NDC 00023-5858-01 — LEVONORGESTREL 20.1 MCG/DAY IU IUD (398 hospitals, 322–700 samples)
• NDC 69618-0050-51 — 12 HOUR DECONGESTANT 0.05 % NA SOLN (203 hospitals, 682–700 samples)
• NDC 00006-4831-41 — HEPATITIS A VACCINE 25 UNIT/0.5ML IM SUSP (163 hospitals, 619–700 samples)
• NDC 70594-0079-02 — PIPERACILLIN-TAZOBACTAM 3.375 GRAM INTRAVENOUS SOLUTION (74 hospitals, 70–700 samples)
• NDC 00641-9219-10 — DILTIAZEM HCL 125 MG/25ML IV SOLN (158 hospitals, 268–700 samples)
• NDC 65162-0791-08 — Lidocaine 5 % Ptmd patch 30 Each BOX (274 hospitals, 637–700 samples)
• NDC 00781-3516-75 — methylPREDNISolone Ac Inj 80 mg/mL 5 mL (26 hospitals, 529–700 samples)
• NDC 00338-9666-35 — DEXTROSE 5 % IN WATER (D5W) INTRAVENOUS MINIBAG PLUS (4 hospitals, 700 samples)
• NDC 37000-0024-44 — PSYLLIUM POWDER PACKET 51.7% (118 hospitals, 654–699 samples)
• NDC 16714-0247-01 — VANCOMYCIN 500 MG INTRAVENOUS SOLUTION (104 hospitals, 104–698 samples)
• NDC 00536-1219-94 — POLYETHYL GLYCOL-PROPYL GLYCOL 0.4-0.3 % SOLUTION 15 ML BOTTLE (85 hospitals, 635–698 samples)
• NDC 00075-7700-60 — Riluzole Tab 50 mg (23 hospitals, 680–698 samples)
• NDC 264420452 — MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (43 hospitals, 527–698 samples)
• NDC 409116218 — Bupivacaine HCl Preservative Free (PF) Inj 0.5% (58 hospitals, 437–698 samples)
• NDC 00121-0914-00 — IBUPROFEN CHILDRENS 100 MG/5ML PO SUSP (292 hospitals, 499–697 samples)
• NDC 60219-1706-01 — PREDNISONE 5 MG PO TABS (102 hospitals, 418–697 samples)
• NDC 65219-0256-00 — PIPERACILLIN-TAZOBACTAM 40.5 GRAM INTRAVENOUS SOLUTION (132 hospitals, 184–697 samples)
• NDC 64380-0949-06 — predniSONE 50 mg tablet (190 hospitals, 418–697 samples)
• NDC 00781-3244-94 — cycloPHOSphamide 1 gram intravenous powder for solution (419 hospitals, 110–695 samples)
• NDC CHCO1-8111-85 — FENTANYL PCA 10 MCG/ML OPIOID TOLERANT - NON WEIGHT BASED (1 hospital, 263–695 samples)
• NDC CHCO1-8112-56 — FENTANYL PCA 10 MCG/ML OPIOID TOLERANT - NON WEIGHT BASED (1 hospital, 263–695 samples)
• NDC 63323-0751-05 — PHENYLEPHRINE HCL (PRESSORS) 10 MG/ML IV SOLN (195 hospitals, 100–694 samples)
• NDC 66993-0844-62 — PREDNISOLONE SODIUM PHOSPHATE 10 MG PO TBDP (13 hospitals, 99–693 samples)
• NDC 409116502 — BUPivacaine (PF) 0.75 % (7.5 mg/mL) Soln 30 mL VIAL (124 hospitals, 476–692 samples)
• NDC 00409-0144-21 — AZITHROMYCIN 500 MG INTRAVENOUS SOLUTION (87 hospitals, 368–692 samples)
• NDC 00093-0223-19 — SUMAtriptan 50 mg Tab (39 hospitals, 611–692 samples)
• NDC 24208-0585-64 — TROPICAMIDE 1 % OP SOLN (339 hospitals, 620–692 samples)
• NDC 00338-9549-24 — CLINDAMYCIN PHOSPHATE IN NACL 600-0.9 MG/50ML-% IV SOLN (338 hospitals, 323–692 samples)
• NDC 55150-0302-01 — PHENYLEPHRINE 10 MG/ML INJECTION SOLUTION (78 hospitals, 89–692 samples)
• NDC 143933001 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (28 hospitals, 476–692 samples)
• NDC 143933301 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (28 hospitals, 476–692 samples)
• NDC 143978501 — Valproate Sodium Inj 100 MG/ML (74 hospitals, 395–692 samples)
• NDC 409116519 — BUPIVACAINE (PF) 0.75 % (7.5 MG/ML) INJECTION SOLUTION (37 hospitals, 476–692 samples)
• NDC 409155919 — MARCAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (33 hospitals, 476–692 samples)
• NDC 36000-0092-01 — BUPivacaine (PF) 0.75 % (7.5 mg/mL) in 8.25 % dextrose injection (96 hospitals, 646–691 samples)
• NDC 904673971 — 00904-6739-71 - acetaminophen 160 mg/5 mL Liquid (9 hospitals, 646–691 samples)
• NDC 00075-8030-01 — ENOXAPARIN 300 MG/3 ML SUBCUTANEOUS SOLUTION (71 hospitals, 313–691 samples)
• NDC 15082-0221-53 — COMPOUNDED DRUG, NOT OTHERWISE CLASSIFIED (11 hospitals, 376–691 samples)
• NDC 69374-0526-20 — FENTANYL 2 MCG/ML ROPIVACAINE 0.1% IN NS OB PIB + PCEA PREMIX (SUPER) (33 hospitals, 231–690 samples)
• NDC 6411903 — human papillomavirus 9-valent vaccine (PF) 0.5 mL Susp 0.5 mL VIAL (83 hospitals, 528–690 samples)
• NDC 81033-0412-51 — POTASSIUM CHLORIDE 20 MEQ/15ML (10%) SOLUTION (88 hospitals, 636–690 samples)
• NDC 641615101 — HYDROMORPHONE (PF) 2 MG/ML INJECTION SOLUTION (48 hospitals, 276–690 samples)
• NDC 16864-0240-01 — CALCIUM ACETATE 952 MG-ALUMINUM SULFATE 1,347 MG TOPICAL POWDER PACKET [9020] (168 hospitals, 653–689 samples)
• NDC 00904-6001-61 — LEVETIRACETAM 250 MG TABLET [26816] (17 hospitals, 644–689 samples)
• NDC 60505-0834-04 — cefePIME Inj 1 GM/10 mL (IV) (90 hospitals, 365–689 samples)